| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |